Not a big fan of TRXC for US market but abroad the tech could do well ... UK ahead of US going to 3mm and also seems like lower cost per procedure which is vital for European and other countries abroad if they are going to be able to purchase robots.. to date ISRG has not been successful in Europe due to high procedure costs.
Also, has eye tracking for camera and some form of haptic and AI . Decent IP.
We will see where TRXC vs. TMDI end up in next 12-18 months. TMDI lost too much time getting to market and other good SP and Endoluminal tech out there ...
News 
Market Data 
Discover 
